4.5 Review

Insights Into Sepsis Therapeutic Design Based on the Apoptotic Death Pathway

Journal

JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 114, Issue 4, Pages 354-365

Publisher

JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.10R04CR

Keywords

sepsis; apoptosis; death receptor; acute lung injury; endothelial cell; gene therapy

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan
  2. Grants-in-Aid for Scientific Research [21590271] Funding Source: KAKEN

Ask authors/readers for more resources

Sepsis remains the leading cause of death in critically ill patients A major problem contributing to sepsis-related high mortality is the lack of effective medical treatment Thus, the key goal in critical care medicine is to develop novel therapeutic strategies that will impact favorably on septic patient outcome While it is generally accepted that sepsis is an inflammatory state resulting from the systemic response to infection, apoptosis is implicated to be an important mechanism of the death of lymphocytes, gastrointestinal and lung epithelial cells, and vascular endothelial cells associated with the development of multiple organ failure in sepsis The pivotal role of cell apoptosis is now highlighted by multiple studies demonstrating that prevention of cell apoptosis can improve survival in clinically relevant animal models of sepsis In this review article, we address the scientific rationale for remedying apoptotic cell death in sepsis and propose that therapeutic efforts aimed at blocking cell signaling pathways leading to apoptosis may represent an attractive target for sepsis therapy

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available